Ava Raises $30 Million for Fertility Tracking Wristband
*By Christian Smith*
Ava, the medtech company that makes wristbands for women tracking their fertility, announced Wednesday that it raised $30 million in Series B funding, money its co-founder said would be used to continue the company's research.
"Women's health and women's health research has been underfunded for the last decade," Lea von Bidder, Ava's co-founder, said in an interview with Cheddar. "We want to do a lot of research in different fields of women's health ー be it pregnancy monitoring, be it contraception, be it menopause ーand hope to give women insights about their body and health."
Ava conducts its research through clinical trials with the University Hospital of Zurich, where the company was founded in 2014.
Its wearable tracker is like a Fitbit for fertility, monitoring nine physiological metrics including heart and breathing rates, skin temperature, and heat loss to determine a woman's fertility cycle. Von Bidder said the company's research shows that the device is 89 percent accurate in predicting the 5.3 fertile days in a woman's cycle. In addition to the tracker, Ava also offers an app, which tracks a woman's health during her pregnancy.
So far, 10,000 babies have been born to mothers using the Ava tracker, the company announced on Wednesday.
Ava's founder said they want to offer contraception and family-planning products, too, but the company doesn't have a time frame for these types of products.
"Ava at this point is not a contraceptive yet," von Bidden said. "We are working really hard on making that happen."
For the full interview, [click here](https://cheddar.com/videos/fertility-tracking-company-ava-raises-30-million-in-series-b-funding-round).
The bank said it regrets its involvement with Epstein over the years that he was a JPMorgan client. The settlement must still be approved by the judge in the case.
Billionaire investor turned philanthropist George Soros is ceding control of his $25 billion empire to a younger son, Alexander Soros, according to an exclusive interview with The Wall Street Journal published online Sunday.
UBS said Monday that it has completed its takeover of embattled rival Credit Suisse, nearly three months after the Swiss government hastily arranged a rescue deal to combine the country's two largest banks in a bid to safeguard Switzerland’s reputation as a global financial center and choke off market turmoil.
Gene sequencing test maker Illumina Inc. said Sunday that its board has accepted the resignation of its CEO and director, Francis deSouza, effective immediately.
“Any consumer can tell you that online airline bookings are confusing enough," said William McGee, an aviation expert at the American Economic Liberties Project. "The last thing we need is to roll back an existing protection that provides effective transparency.”
Cheddar News checks in to see what to look out for Next Week on the Street as former president Donald Trump makes an appearance in federal court after being indicted. Investors will also keep an eye on the Federal Reserve meeting to see what comes out of that while earnings continue to pour in.
